Life has barely been smooth for Colgate in the last few quarters with the competitive intensity in oralcare only going up with every passing day. Almost all key players including Hindustan......
The banking sector, which had seen good set of numbers in the third quarter, is likely to report subdued earnings in the fourth quarter of 2008-09 due to slowdown in credit growth and pressure on......
At a time when various industries have been hit due to the current economic slowdown, the domestic pharmaceutical market registered a value growth of 14.4 per cent in January and 9.9 per cent in......
Drug major Ranbaxy Laboratories could suffer a potential revenue loss to the tune of Rs 300 crore (Rs 3 billion) due to delay in receiving approval from the US Food and Drug Administration (FDA)......
Drug major Wockhardt, which is trying to raise funds for meeting payments to its foreign currency convertible bond holders,said on Friday the company was planning to raise Rs 500 crore (Rs 5......